Its protein expression was significantly associated with ER expression in breast cancer tissues, and it had distinct regulatory effects on HER2 and Bcl-2 expression in ER+ PR+ HER2− and ER− PR− HER2− cell lines [3]. This evidence concerns the gene PGR and breast carcinoma.